Tianjin Chase Sun Pharmaceutical Co., Ltd. (300026) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Tianjin Chase Sun Pharmaceutical Co., Ltd.

Why is Tianjin Chase Sun Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -7.70% and Operating profit at -28.53% over the last 5 years

Flat results in Mar 26

OPERATING CASH FLOW(Y) Lowest at CNY 798.76 MM
INVENTORY TURNOVER RATIO(HY) Lowest at 1.32 times
DEBTORS TURNOVER RATIO(HY) Lowest at 1.69 times

With ROE of 0.80%, it has a fair valuation with a 0.98 Price to Book Value

Over the past year, while the stock has generated a return of -18.53%, its profits have risen by 125.3% ; the PEG ratio of the company is 1
At the current price, the company has a high dividend yield of 1

Below par performance in long term as well as near term

Along with generating -18.53% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Tianjin Chase Sun Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Tianjin Chase Sun Pharmaceutical Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Tianjin Chase Sun Pharmaceutical Co., Ltd.

-16.49%

-0.53

24.05%

China Shanghai Composite

21.43%

1.73

13.79%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-7.70%

EBIT Growth (5y)

-28.53%

EBIT to Interest (avg)

10.63

Debt to EBITDA (avg)

0.21

Net Debt to Equity (avg)

-0.07

Sales to Capital Employed (avg)

0.58

Tax Ratio

42.68%

Dividend Payout Ratio

161.29%

Pledged Shares

Institutional Holding

ROCE (avg)

6.54%

ROE (avg)

5.79%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

122

Industry P/E

Price to Book Value

0.98

EV to EBIT

50.48

EV to EBITDA

17.64

EV to Capital Employed

0.97

EV to Sales

1.56

PEG Ratio

0.98

Dividend Yield

0.96%

ROCE (Latest)

1.93%

ROE (Latest)

0.80%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

21What is working for the Company

DEBT-EQUITY RATIO (HY)

Lowest at -11.83 %

RAW MATERIAL COST(Y)

Fallen by -19.08% (YoY

PRE-TAX PROFIT(Q)

Highest at CNY 84.75 MM

NET PROFIT(Q)

Highest at CNY 65.71 MM

EPS(Q)

Highest at CNY 0.02

-15What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 798.76 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.32 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 1.69 times

NET SALES(Q)

At CNY 1,130.23 MM has Fallen at -8.5%

OPERATING PROFIT MARGIN(Q)

Lowest at 7.45 %

Here's what is working for Tianjin Chase Sun Pharmaceutical Co., Ltd.

Net Profit

At CNY 65.71 MM has Grown at 352.44%

over average net sales of the previous four periods of CNY 14.52 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Pre-Tax Profit

At CNY 84.75 MM has Grown at 169.24%

over average net sales of the previous four periods of CNY 31.48 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Debt-Equity Ratio

Lowest at -11.83 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Pre-Tax Profit

Highest at CNY 84.75 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 65.71 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.02

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Raw Material Cost

Fallen by -19.08% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Tianjin Chase Sun Pharmaceutical Co., Ltd.

Operating Cash Flow

Lowest at CNY 798.76 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales

At CNY 1,130.23 MM has Fallen at -8.5%

over average net sales of the previous four periods of CNY 1,235.28 MM

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit Margin

Lowest at 7.45 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Inventory Turnover Ratio

Lowest at 1.32 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 1.69 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio